Covered recipient · General Payments record
NATHAN BECKER
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$3,997.05
- Reported across 240 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $653.19 | 27 |
| Education | $14.52 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $289.64 | 10 |
| IBSA Pharma Inc. | $219.91 | 10 |
| ABBVIE INC. | $89.20 | 4 |
| Novo Nordisk AS | $38.40 | 2 |
| Radius Health, Inc. | $30.56 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.38 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297766 | CMS |
| ABBVIE INC. | $21.02 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297768 | CMS |
| ABBVIE INC. | $24.52 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297770 | CMS |
| ABBVIE INC. | $13.28 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103297772 | CMS |
| IBSA Pharma Inc. | $24.63 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983528 | CMS |
| IBSA Pharma Inc. | $19.70 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983530 | CMS |
| IBSA Pharma Inc. | $24.23 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983532 | CMS |
| IBSA Pharma Inc. | $22.22 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983534 | CMS |
| IBSA Pharma Inc. | $24.79 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983538 | CMS |
| IBSA Pharma Inc. | $24.19 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983540 | CMS |
| IBSA Pharma Inc. | $22.52 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142983542 | CMS |
| IBSA Pharma Inc. | $14.15 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142972703 | CMS |
| IBSA Pharma Inc. | $21.80 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974940 | CMS |
| IBSA Pharma Inc. | $21.68 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142987604 | CMS |
| Lilly USA, LLC | $26.59 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135266590 | CMS |
| Lilly USA, LLC | $27.86 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135283208 | CMS |
| Lilly USA, LLC | $34.20 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135236436 | CMS |
| Lilly USA, LLC | $25.42 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135266594 | CMS |
| Lilly USA, LLC | $34.92 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238105 | CMS |
| Lilly USA, LLC | $26.30 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135236440 | CMS |
| Lilly USA, LLC | $34.77 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135221440 | CMS |
| Lilly USA, LLC | $23.78 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135271790 | CMS |
| Lilly USA, LLC | $28.64 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135175829 | CMS |
| Lilly USA, LLC | $27.16 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238101 | CMS |
| Novo Nordisk Inc | $24.33 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096733297 | CMS |
| Novo Nordisk Inc | $14.07 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097062680 | CMS |
| Radius Health, Inc. | $16.04 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979131 | CMS |
| Radius Health, Inc. | $14.52 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1089979134 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.